# Notice of Class Deviation From Competition Requirements for HRSA-15-021: Quality Improvement Capacity for Impact Project
**AGENCY:**
Health Resources and Services Administration (HRSA), Department of Health and Human Services.
**ACTION:**
Notice.
**SUMMARY:**
HRSA is providing supplemental funding for one year to the current recipients of HRSA-15-021, Quality Improvement Capacity for Impact Project.
**FOR FURTHER INFORMATION CONTACT:**
Austin Demby, Ph.D., MPH, Acting Director,
Office of Global Health, Office of the Administrator, HRSA, 5600 Fishers Lane, 09N09, Rockville, MD 20857, Phone: (301) 443-0581, Email: *[email protected].*
**SUPPLEMENTARY INFORMATION:**
*Recipients of the Award:* The Regents of the University of California San Francisco (UCSF-U1NHA31422) and the Trustees of Columbia University in the City of New York (ICAP-U1NHA28555).
*Amount of Award:* HRSA has awarded two grants totaling $6 million noted in Table 1.
Period of Supplemental Funding: September 30, 2020—September 29, 2021,
CFDA Number: 93.266
| Grant number | Award recipient name | Extension length | Award amount |
| --- | --- | --- | --- |
| UCSF-U1NHA31422 | The Regents of the University of California San Francisco | 1 Year | $4,000,000 |
| ICAP-U1NHA28555 | Trustees of Columbia University in the City of New York | 1 Year | 2,000,000 |
*Justification:* The purpose of these cooperative agreements is to save lives, prevent HIV infections, and accelerate progress toward achieving HIV/AIDS epidemic control in more than 50 countries around the world. Recipients have completed certain project activities, but evaluation and transition to scale-up has been interrupted by the COVID-19 pandemic and associated country-specific restrictions. This notice extends the current project period for HRSA-15-021, Quality Improvement Capacity for Impact Project, by one year until September 29, 2021, to ensure the orderly conclusion of these projects while facilitating virtual stakeholder engagement during the COVID-19 pandemic.
Authority: United States President's Emergency Plan for AIDS Relief authorized by Public Law 108-25 (the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003) [22 U.S.C. 7601, *et seq.* ]; and Public Law 110-293 (the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), as reauthorized and amended by Public Law 113-56 (the President's Emergency Plan for AIDS Relief Stewardship and Oversight Act of 2013). See, *e.g.,* 22 U.S.C. 7603 and 22 U.S.C. 2151b-2(b) (1)(B), 2151b-2(c)(1), and 2151b-2(d)(6)(G)(ii).
Thomas J. Engels,
Administrator.